Treatment Strategies and Outcomes of Medication Related Osteonecrosis of the Jaw (MRONJ)
Gol EB
Abstract
Open-access reader
Gol EB
Abstract
Open-access reader
Medication Reliated Osteonecrosis of The Jaws (MRONJ); Caused by maxillofacial surgical procedures performed during or after antiresorptive, antiangiogenic and bisphosphonate treatments; It is a newly defined disease and its etiopathogenesis is still not fully understood. Studies on the definition, staging and treatment approaches of the disease are evaluated by the commission formed by the American Association of Maxillofacial Surgeons, and guidelines expressing opinions on these issues are published; Discussions still continue on the treatment approaches of the disease. Conservative, surgical, alternative and their combinations methods are used in the treatment of the disease, depending on the level of bone and soft tissues affected.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Medication Reliated Osteonecrosis of The Jaws (MRONJ); Caused by maxillofacial surgical procedures performed during or after antiresorptive, antiangiogenic and bisphosphonate treatments; It is a newly defined disease and its etiopathogenesis is still not fully understood. Studies on the definition, staging and treatment approaches of the disease are evaluated by the commission formed by the American Association of Maxillofacial Surgeons, and guidelines expressing opinions on these issues are published; Discussions still continue on the treatment approaches of the disease. Conservative, surgical, alternative and their combinations methods are used in the treatment of the disease, depending on the level of bone and soft tissues affected.
Key concepts: Osteonecrosis of the jaw, Medicine, Bisphosphonate, Bisphosphonate-associated osteonecrosis of the jaw, Disease, Dentistry, Bone Density Conservation Agents, Intensive care medicine